ArisGlobal to Co-Present "Enhancing Operations: Enabling Digital Transformation With Next-Gen Technology" at World Drug Safety Congress Americas

Miami (ots/PRNewswire) - ArisGlobal, a leading provider of life sciences
software that automates core drug development functions for over 250 life
sciences companies, is thrilled to announce their participation at the World
Drug Safety Congress Americas 2020
(https://www.terrapinn.com/conference/world-drug-safety-us/index.stm), March 24
- 25, 2020 at the Seaport Hotel in Boston, Massachusetts. Along with a large
drug manufacturer, they will be co-presenting a session titled "Enhancing
Operations: Enabling Digital Transformation with Next-Gen Technology". The
presentation will explore new technology with a focus on the importance of
artificial intelligence and automation in the life sciences industry.

"The time is now for the pharmaceutical industry to embrace automation
technology and stay abreast with the progress made in other industries," said
Aman Wasan, Vice President, Global Client Partners at ArisGlobal. "Cognitive
computing tools can augment the expertise of pharmacovigilance staff, reduce the
volume of manual repetitive tasks, and allow them to focus on more intelligent,
value-added tasks. This session will share the efficiencies gained from a real
case study."

ArisGlobal is a Platinum Sponsor of the conference, exhibiting and showcasing
the LifeSphere® Safety (https://www.arisglobal.com/products/lifesphere-safety/),
cognitive computing platform, in Booth #27. Attendees are invited to meet with
ArisGlobal staff to learn about its innovative and leading pharmacovigilance and
safety platform.

Click here to schedule a meeting (http://bit.ly/38TUkA3) with us while at the
event, or to connect with one of our team members.

About ArisGlobal

ArisGlobal is transforming the way today's most successful Life Sciences
companies develop breakthroughs and bring new products to market. Our end-to-end
drug development technology platform, LifeSphere®, integrates our proprietary
Nava® cognitive computing engine to automate all core functions of the drug
development lifecycle. Designed with deep expertise and a long-term perspective
that spans more than 30 years, LifeSphere® is a unified platform that boosts
efficiency, ensures compliance, delivers actionable insights, and lowers total
cost of ownership through multi-tenant SaaS architecture.

Headquartered in the United States, ArisGlobal has regional offices in Europe,
India, Japan and China. For more updates, follow ArisGlobal on LinkedIn
(https://www.linkedin.com/company/aris-global/) and Twitter
(https://twitter.com/aris_global).

Logo - https://mma.prnewswire.com/media/523994/ArisGlobal_Logo.jpg

Additional content: https://www.presseportal.de/pm/119824/4537390
OTS: ArisGlobal

Original-Content von: ArisGlobal, übermittelt durch news aktuell